<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05078814</url>
  </required_header>
  <id_info>
    <org_study_id>CMMC10705-003</org_study_id>
    <nct_id>NCT05078814</nct_id>
  </id_info>
  <brief_title>The Prevalence Survey of ALDH Gene Family in Patients With Peripheral Arterial Occlusive Disease or Acute Coronary Syndrome</brief_title>
  <official_title>The Prevalence Survey of ALDH Gene Family in Patients With Peripheral Arterial Occlusive Disease or Acute Coronary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chimei Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chimei Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aldehyde dehydrogenase 2 (ALDH2) is an important enzyme protecting human from the&#xD;
      accumulation of aldehyde, the main metabolites of alcohol. The deficiency of ALDH2 gene&#xD;
      results in flush and hang over post drinking and most importantly it has been found&#xD;
      associated with the incidence of cancer and post myocardial infarction (MI) heart failure. In&#xD;
      the previous studies, ALDH2 decreased the ischemic territory post infarction and using a&#xD;
      large scaled interaction of genetic variants and ALDH2 as an instrument, the threats of&#xD;
      alcohol consumption on Asians' cardiovascular health was underscored. Furthermore, in a&#xD;
      meta-analysis reviewing 12 case-control studies also indicated an increase of 48% risks in&#xD;
      patients with ALDH2 deficiency. Notably, the genetic deficiency is most prevalent in Asians.&#xD;
      In Taiwan one of every two individuals may be the victim and the high prevalence is counted&#xD;
      as the top of the world. However, a large scaled prospective study focusing on the prevalence&#xD;
      of ALDH2 deficiency in patients with peripheral artery occlusive disease (PAOD) or acute&#xD;
      coronary syndrome （ACS）remains lacking.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>The incidence of MALE(major adverse limb events) in peripheral arterial disease and acute coronary disease.</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of MACCE(major adverse cardiac and cerebrovascular events) in peripheral arterial disease and acute coronary disease.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Peripheral Artery Occlusive Disease</condition>
  <condition>Acute Coronary Syndrome</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational research</intervention_name>
    <description>Observational research</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Diagnosed as peripheral arterial obstruction or acute coronary syndrome.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age≧20 y/o&#xD;
&#xD;
          2. Using ankle-brachial index (ABI)&lt; 0.9, angiography, vascular duplex, CAT scan or&#xD;
             cardiologists'impression to confirm the diagnosis of PAOD&#xD;
&#xD;
          3. Clinical presentation of claudication&#xD;
&#xD;
          4. diagnosis of ACS&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  If the patient refuses to be included in this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wei-Ting Chang</last_name>
    <phone>+886-6-2812811</phone>
    <phone_ext>57332</phone_ext>
    <email>cmcvecho2@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wei-Ting Chang</name>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei-Ting Chang</last_name>
      <phone>+886-6-2812811</phone>
      <phone_ext>57332</phone_ext>
      <email>cmcvecho2@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chimei Medical Center</investigator_affiliation>
    <investigator_full_name>Wei-Ting Chang</investigator_full_name>
    <investigator_title>Doctor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Peripheral Artery Occlusive Disease or Acute Coronary Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

